Cystatin C as a biomarker of chronic kidney disease: latest developments
Introduction Chronic kidney disease (CKD) is common, occurring in over 10% of individuals globally, and is increasing in prevalence. The limitations of traditional biomarkers of renal dysfunction, such as serum creatinine, have been well demonstrated in the literature. Therefore, augmenting clinical...
Tallennettuna:
| Päätekijät: | , , |
|---|---|
| Aineistotyyppi: | Revisão |
| Kieli: | englanti |
| Julkaistu: |
2020
|
| Linkit: | https://doi.org/10.1080/14737159.2020.1768849 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|
Lisää ensimmäinen kommentti!